Hence, we investigated the type and frequency of POLE mutations in patients with MSS CRC of a well characterized population-based patient cohort study and analyzed the associations between the mutation status and all major CRC-related epidemiological, pathological, genetic and clinical parameters, including overall survival (OS) and disease-specific survival (DSS). This evidence concerns the gene POLE and colorectal carcinoma.